BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF AND Treatment
1214 results:

  • 1. Injectable composite hydrogels embedded with gallium-based liquid metal particles for solid breast cancer treatment via chemo-photothermal combination.
    Lee W; Shin MJ; Kim S; Lee CE; Choi J; Koo HJ; Choi MJ; Kim JH; Kim K
    Acta Biomater; 2024 May; 180():140-153. PubMed ID: 38604467
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Exploring the therapeutic potential of tonic Chinese herbal medicine for gynecological disorders: An updated review.
    He Q; Wan S; Jiang M; Li W; Zhang Y; Zhang L; Wu M; Lin J; Zou L; Hu Y
    J Ethnopharmacol; 2024 Jul; 329():118144. PubMed ID: 38583732
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Neoadjuvant immune checkpoint blockade enhances local and systemic tumor immunity in head and neck cancer.
    Zhao Y; Wucherpfennig KW
    Curr Opin Oncol; 2024 May; 36(3):136-142. PubMed ID: 38573202
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A metabolomics approach reveals metabolic disturbance of human cholangiocarcinoma cells after parthenolide treatment.
    He Y; Yu Q; Ma X; Lv D; Wang H; Qiu W; Chen XF; Jiao Y; Liu Y
    J Ethnopharmacol; 2024 Jun; 328():118075. PubMed ID: 38513779
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Zirconium-containing nanoscale coordination polymers for positron emission tomography and fluorescence-guided cargo delivery to triple-negative breast tumors.
    Li YP; Pan ZW; Jiang YJ; Peng YY; Cai T; Hong H; Wang XF
    Acta Biomater; 2024 Apr; 179():313-324. PubMed ID: 38490483
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Towards clinical adherence monitoring of oral endocrine breast cancer therapies by LC-HRMS-method development, validation, comparison of four sample matrices, and proof of concept.
    Jacobs CM; Radosa JC; Wagmann L; Zimmermann JSM; Kaya AC; Aygün A; Edel T; Stotz L; Ismaeil M; Solomayer EF; Meyer MR
    Anal Bioanal Chem; 2024 May; 416(12):2969-2981. PubMed ID: 38488952
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A Phase II Study of Rucaparib Monotherapy in Nonmetastatic, Hormone-Sensitive Prostate cancer Demonstrating "BRCAness" Genotype (ROAR).
    Sahu KK; Li H; Mathew Thomas V; Benson M; Boucher K; Gupta S; Kohli M; Swami U; Agarwal N; Maughan BL
    Oncologist; 2024 May; 29(5):450-e725. PubMed ID: 38452035
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. treatment patterns and outcomes in metastatic castration-resistant prostate cancer patients with and without somatic or germline alterations in homologous recombination repair genes.
    Olmos D; Lorente D; Alameda D; Cattrini C; Romero-Laorden N; Lozano R; Lopez-Casas PP; Jambrina A; Capone C; Vanden Broecke AM; Trevisan M; Van Sanden S; Jürgens A; Herrera-Imbroda B; Castro E
    Ann Oncol; 2024 May; 35(5):458-472. PubMed ID: 38417742
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Addressing Residual Disease in HER2-Positive and Triple-Negative breast cancer: What Is Next?
    Schlam I; Dower J; Lynce F
    Curr Oncol Rep; 2024 Apr; 26(4):336-345. PubMed ID: 38393609
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Integrating serum pharmacochemistry and network pharmacology to explore the molecular mechanisms of Acanthopanax senticosus (Rupr. & Maxim.) Harms on attenuating doxorubicin-induced myocardial injury.
    Zhang X; Zhang Q; Yu M; Zhang Y; He T; Qiu Z; Qiu Y; Wang W
    J Ethnopharmacol; 2024 Jan; 319(Pt 3):117349. PubMed ID: 38380572
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. EXPRESSION PROFILE OF miR-145, -182, -21, -27a, -29b, and -34a IN breast cancer PATIENTS OF YOUNG AGE.
    Chekhun V; Borikun T; Mushii O; Zadvornyi T; Martyniuk О; Kashuba E; Bazas V; Hrybach S; Krotevych M; Lyalkin S; Lukianova N
    Exp Oncol; 2024 Feb; 45(4):421-431. PubMed ID: 38328848
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. ASSESSMENT OF CIRCULATING miRNA LEVELS IN breast cancer PATIENTS DEPENDING ON CLINICAL CHARACTERISTICS AND CHEMOTHERAPY.
    Harashchenko О
    Exp Oncol; 2024 Feb; 45(4):451-456. PubMed ID: 38328845
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Natural History of Germline BRCA1 Mutated and BRCA Wild-type Triple-negative breast cancer.
    Gardi N; Chaubal R; Parab P; Pachakar S; Kulkarni S; Shet T; Joshi S; Kembhavi Y; Chandrani P; Quist J; Kowtal P; Grigoriadis A; Sarin R; Govindarajan R; Gupta S
    Cancer Res Commun; 2024 Feb; 4(2):404-417. PubMed ID: 38315150
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Systemic platelet inhibition with localized chemotherapy by an injectable ROS-scavenging gel against postsurgical breast cancer recurrence and metastasis.
    Gui J; Zhu Y; Chen X; Gong T; Zhang Z; Yu R; Fu Y
    Acta Biomater; 2024 Mar; 177():388-399. PubMed ID: 38307476
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The reunion with my patients: their journey and experience 30 years after their intervention for adolescent idiopathic scoliosis via CD instrumentation.
    Pérez-Grueso FJS; Moreno-Manzanaro L; Pizones J
    Spine Deform; 2024 May; 12(3):671-679. PubMed ID: 38305991
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Dye-augmented bandgap engineering of a degradable cascade nanoreactor for tumor immune microenvironment-enhanced dynamic phototherapy of breast cancer.
    He Z; Du J; Wang Q; Chen G; Li X; Zhang Z; Wang S; Jing W; Miao Q; Li Y; Miao Y; Wu J
    Acta Biomater; 2024 Mar; 176():390-404. PubMed ID: 38244657
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. PARP Inhibitors in breast cancer: a Short Communication.
    Daly GR; AlRawashdeh MM; McGrath J; Dowling GP; Cox L; Naidoo S; Vareslija D; Hill ADK; Young L
    Curr Oncol Rep; 2024 Feb; 26(2):103-113. PubMed ID: 38236558
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Male breast cancer: a Review on Diagnosis, treatment, and Survivorship.
    Bhardwaj PV; Gupta S; Elyash A; Teplinsky E
    Curr Oncol Rep; 2024 Jan; 26(1):34-45. PubMed ID: 38224426
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Immunotherapy for Early-Stage Triple Negative breast cancer: Is Earlier Better?
    Song F; Tarantino P; Garrido-Castro A; Lynce F; Tolaney SM; Schlam I
    Curr Oncol Rep; 2024 Jan; 26(1):21-33. PubMed ID: 38198112
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Updates in the treatment of HR+HER2- breast cancer.
    Baclig NV; McCann KE
    Curr Opin Obstet Gynecol; 2024 Feb; 36(1):57-63. PubMed ID: 38170552
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 61.